Skip to main content

IntriCon Appoints Heather Rider to its Board of Directors

Written by Customer Service on . Posted in Public Companies.

ARDEN HILLS, Minn., March 19, 2020 (GLOBE NEWSWIRE) — IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced the appointment of Heather Rider to the company’s Board of Directors, effective March 20, 2020.
“I am delighted to welcome Heather to our board of directors,” said Mark Gorder, president and chief executive officer of IntriCon. “One of the top priorities we identified for 2020 is to implement an organizational structure that best aligns with our focus on driving a sustainable pipeline of growth opportunities. Heather has the ideal background given her rich experience guiding successful medical technology companies and we are confident she can immediately add valuable insights that will help us achieve our goals.”Ms. Rider’s experience includes more than 30 years as a leader in global human resources for the medical technology industry. She is currently a Director of Inogen Inc. and serves as Chair, Compensation, Nominating and Governance Committee. Her career includes executive level positions with medical device companies such as Intuitive Surgical, Inc. and Alphatec Spine, Inc. She also served in leadership roles in the human resources organizations of Sunrise Medical and Biosense Webster, a member of the J & J family of companies. Most recently, Ms. Rider was vice president of global human resources for Cymer, Inc., the leader in developing light sources used by chipmakers worldwide to pattern advanced semiconductor chips.“Seeking Board diversity has been another important goal at IntriCon and we are pleased to be driving this initiative forward as we welcome Heather to the leadership team,” said Philip Smith, Chair of the Board of Directors.  “Heather has an excellent record of accomplishment in domestic and international human resource practices, organization change, mergers and acquisitions and site operations management.  Her skills will be highly complementary to our existing Board.”“It is great a privilege to join IntriCon and I look forward to working with my fellow board members and the company’s leadership team to contribute to its future growth and success,” said Heather Rider. “The future at IntriCon is very exciting as the growing need for micro-miniature body-worn devices presents many exciting opportunities to increase the quality of life for patients.”  About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better connected devices. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investorrelations@intricon.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.